Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07591389 · ClinicalTrials.gov registry record · NA
Promoting Radon Testing Among Mothers of Young Children
A NA study, sponsored by University of North Dakota.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07591389: Recruiting NA study, sponsored by University of North Dakota.
NCT07591389 is a NA study that is actively recruiting participants, run by University of North Dakota. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07591389, a NA study, is actively recruiting participants, sponsored by University of North Dakota.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Radon is the second-leading cause of lung cancer after smoking and may contribute to other cancer deaths; children are especially vulnerable due to a larger lung surface area and higher respiratory rates. The goal of this research is to test the feasibility of the radon app to promote radon testing among mothers of children aged 4 or younger when they receive a free radon test kit.
Primary Outcome
T1 (baseline: pre-exposure survey, distribution of free radon test kit). The pre-expsosure survey will measure: Primary endpoints: (1) Radon knowledge, 20 true/false items); (2) self-efficacy, response efficacy, and sharing intention (7-point Likert).
Interventions
- BEHAVIORAL The radon app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07591389 shows while recruiting
NCT07591389 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which The radon app is the first listed.
NCT07591389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07591389 about?
NCT07591389 is a clinical study titled "Promoting Radon Testing Among Mothers of Young Children". Radon is the second-leading cause of lung cancer after smoking and may contribute to other cancer deaths; children are especially vulnerable due to a larger lung surface area and higher respiratory rates. The goal of this research is to test the feasibility of the radon app to promote radon testing ...
What is the current status of trial NCT07591389?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-04-10. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07591389?
The interventions under investigation include: The radon app (BEHAVIORAL).
Who is sponsoring clinical trial NCT07591389?
This trial is sponsored by University of North Dakota, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07591389's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI